Entrada Therapeutics, Inc. (TRDA)
TRDA Stock Price Chart
Explore Entrada Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze TRDA price movements and trends.
TRDA Company Profile
Discover essential business fundamentals and corporate details for Entrada Therapeutics, Inc. (TRDA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
29 Oct 2021
Employees
183.00
Website
https://www.entradatx.comCEO
Dipal Doshi
Description
Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in preclinical trail for the treatment of Duchenne muscular dystrophy and myotonic dystrophy type 1. It also engages in the development of EEV-PMO-CAG for the treatment of myotonic dystrophy type 1. The company was formerly known as CycloPorters, Inc. and changed its name to Entrada Therapeutics, Inc. in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.
TRDA Financial Timeline
Browse a chronological timeline of Entrada Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 May 2026
Upcoming earnings on 25 Feb 2026
Upcoming earnings on 4 Nov 2025
EPS estimate is -$1.04, while revenue estimate is $7.03M.
Earnings released on 6 Aug 2025
EPS came in at -$1.04 falling short of the estimated -$0.86 by -20.93%, while revenue for the quarter reached $1.95M , missing expectations by -75.11%.
Earnings released on 8 May 2025
EPS came in at -$0.42 surpassing the estimated -$0.78 by +46.15%, while revenue for the quarter reached $20.56M , beating expectations by +110.40%.
Earnings released on 27 Feb 2025
EPS came in at $0.03 surpassing the estimated -$0.66 by +104.55%, while revenue for the quarter reached $37.40M , beating expectations by +185.04%.
Earnings released on 5 Nov 2024
EPS came in at -$0.35 surpassing the estimated -$0.67 by +47.76%, while revenue for the quarter reached $19.57M , beating expectations by +51.43%.
Earnings released on 13 Aug 2024
EPS came in at $1.55 surpassing the estimated $0.14 by +1.01K%, while revenue for the quarter reached $94.69M , beating expectations by +668.62%.
Earnings released on 7 May 2024
EPS came in at $0.68 surpassing the estimated -$0.59 by +215.25%, while revenue for the quarter reached $59.12M , beating expectations by +294.66%.
Earnings released on 13 Mar 2024
EPS came in at -$0.29 falling short of the estimated -$0.07 by -314.29%, while revenue for the quarter reached $41.85M , beating expectations by +76.65%.
Earnings released on 7 Nov 2023
EPS came in at $1.02 surpassing the estimated -$0.74 by +237.84%, while revenue for the quarter reached $43.74M , beating expectations by +104.27%.
Earnings released on 8 Aug 2023
EPS came in at -$0.78 falling short of the estimated -$0.43 by -81.40%, while revenue for the quarter reached $18.17M , beating expectations by +85.86%.
Earnings released on 10 May 2023
EPS came in at -$0.21 surpassing the estimated -$0.77 by +72.73%, while revenue for the quarter reached $25.26M , beating expectations by +158.28%.
Earnings released on 6 Mar 2023
EPS came in at -$0.79 surpassing the estimated -$0.84 by +5.95%.
Earnings released on 7 Nov 2022
EPS came in at -$0.80 falling short of the estimated -$0.76 by -5.26%.
Earnings released on 11 Aug 2022
EPS came in at -$0.74 falling short of the estimated -$0.72 by -2.78%.
Earnings released on 12 May 2022
EPS came in at -$0.69 falling short of the estimated -$0.65 by -6.15%.
Earnings released on 15 Mar 2022
EPS came in at -$0.89 surpassing the estimated -$1.28 by +30.47%.
Earnings released on 9 Dec 2021
EPS came in at -$9.78 falling short of the estimated -$0.87 by -1.02K%.
Earnings released on 1 Nov 2021
EPS came in at -$0.48 .
Earnings released on 31 Mar 2021
EPS came in at -$0.41 .
Earnings released on 31 Dec 2020
EPS came in at -$0.42 .
Earnings released on 30 Sept 2020
EPS came in at -$0.34 .
TRDA Stock Performance
Access detailed TRDA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.